Abstract
BackgroundThe role of uric acid in development of renal dysfunction (RD) remains controversial. Earlier studies have reported inconsistent results, possibly because of their varying ability to adjust for confounding. The impact of longitudinal change in uric acid on renal outcome has not been assessed previously. We aimed to study the impact of change in serum uric acid (SUA) as well as baseline SUA on the development of RD.MethodsIn a prospective cohort study, we assessed the associations between change in SUA during follow-up, baseline SUA and RD (defined as albumin-creatinine-ratio (ACR) ≥1.13 mg albumin/mmol creatinine and/or eGFR < 60 ml/min/1.73 m2) in a large cohort from a general population participating in the Tromsø Study (n = 2637). Participants were stratified according to tertiles of change in SUA between baseline (1994/95) and follow-up 13 years later. (upper tertile: SUA increasing group, two lower tertiles: SUA non-increasing group). Logistic regression analysis was applied with RD and each component of RD after 7 and 13 years as the dependent variables. Adjustments were made for baseline eGFR, cardiovascular risk factors, and the use of antihypertensive drugs including diuretics.ResultsAfter excluding participants with RD at baseline, SUA increasers, compared to SUA non-increasers, had a doubled risk of RD after 7 years (odds ratio 2.00, (95 % CI 1.45, 2.75)). Odds ratio for RD in SUA increasers after 13 years was 2.18 (95 % CI 1.71, 2.79). The risk of developing ACR ≥1.13 mg/mmol alone was not significantly increased after 7 years (odds ratio 1.30 (95 % CI 0.90, 1.89), but after 13 years (odds ratio 1.43 (95 % CI 1.09, 1.86)). An increase in baseline SUA of 59 μmol/L (1 mg/dL) gave an odds ratio for RD after 13 years of 1.16 (95 % CI 1.04, 1.29).ConclusionAn increase in SUA during follow-up was associated with an increased risk of developing RD after 7 and 13 years.
Highlights
The role of uric acid in development of renal dysfunction (RD) remains controversial
Studying the role of serum uric acid (SUA) in chronic kidney disease (CKD) is difficult since uric acid is excreted primarily by the kidneys, and a decrease in Glomerular filtration rate (GFR) will be accompanied by a rise in SUA level
In this prospective study from a large cohort from the general population we found that being in the highest tertile of SUA change, corresponding to an increase in SUA of more than 33 μmol/L over 13 years, was an independent risk factor for RD defined as slightly increased albumin creatinine ratio (ACR) and/or a moderately reduced Estimated glomerular filtration rate (eGFR)
Summary
The role of uric acid in development of renal dysfunction (RD) remains controversial. We aimed to study the impact of change in serum uric acid (SUA) as well as baseline SUA on the development of RD. Hyperuricemia has been recognized as a risk factor for the incidence and progression of CKD, studies have reported conflicting results [4]. Studying the role of SUA in CKD is difficult since uric acid is excreted primarily by the kidneys, and a decrease in GFR will be accompanied by a rise in SUA level. Multiple regression analyses showed that explanatory factors of eGFR after a 6-year interval were age and SUA at baseline. They concluded that elevation of SUA accelerated the yearly decline in eGFR [5]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.